Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Negatively charged membrane phospholipids, such as phosphatidylserine (PS), phosphatidylinositol, and phosphatidylglycerol, are essential lipid components that play critical roles in membrane structure and cell signaling (Birge et al., 2016, Cell Death & Differentiation). In healthy mammalian cells, these lipids are actively sequestered in the inner leaflet of the plasma membrane, but they become externalized on the surface of apoptotic cells and tumor-associated vascular endothelial cells (Ran and Thorpe, 2002, Int J Radiat Oncol Biol Phys). This surface exposure serves as a 'global' immunosuppressive signal in the tumor microenvironment, facilitating immune evasion (Birge et al., 2016). Therapeutic strategies, such as the monoclonal antibody bavituximab, target exposed PS to reverse this immunosuppression and induce antibody-dependent cellular cytotoxicity (Gerber et al., 2015, Clin Cancer Res). Additionally, anionic phospholipids are primary targets for certain antibiotics; for instance, daptomycin targets phosphatidylglycerol in bacterial membranes to cause depolarization (Pogliano et al., 2012, J Bacteriol). Viral envelopes also frequently expose PS, making them susceptible to PS-targeting agents that block viral entry or trigger immune clearance (Soares et al., 2008, Nat Rev Cancer).
Binding to externalized anionic phospholipids to trigger immune-mediated cell death (ADCC), disrupt membrane permeability, or inhibit viral entry.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Negatively charged membrane phospholipids (PS).